Delivery Order SPE2DB22D1202-SPE2DB25FUSE2

Award Date 2/7/25
Potential Completion Date 2/10/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,366.36 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,302.15 firm fixed-price delivery order contract is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $10,076.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a completion date of November 25, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,252.63 fixed-price delivery order is for the pharmaceutical product RINVOQ ER 15 MG TABLET, with a performance period ending on May 9, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,067.48 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award of $13,651.77 was issued by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product, with a completion date of December 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $16,866.40 and awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, and has a period of performance through November 8, 2024. The contract is a firm fixed price arrangement. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,024.41 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET, a medication, with a completion date of February 4, 2025. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $10,495.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a prescription medication, with a completion date of June 13, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,551.66 contract is a firm fixed-price delivery order for the supply of the medication RINVOQ ER 15 MG TABLET UU 30S. The contract has an ultimate completion date of January 15, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUSE2
    Delivery Order

This federal contract award is a Delivery Order worth $27,556.27 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a period of performance through February 10, 2025. The contract was awarded on a Firm Fixed Price basis without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/9/25, 9:50 AM